Phase I-II

rare disease day 2022

Rare disease research center to use Trialbee recruitment tech

28-Feb-2022 By Jenni Spinner

Ergomed, a global contract research organization, is partnering with Trialbee to improve patient recruitment at its new Rare Disease Innovation Center.

Rare Disease Day 2022

Report shines a light on unique challenges of rare disease patients

24-Feb-2022 By Jenni Spinner

In its latest diversity, equity and inclusion report, Global Genes offers insight into obstacles faced by rare-disease patients from minority communities.

FDA clears Immune-Onc to start trial of Keytruda combo in solid-tumor patients

22-Feb-2022 By Nick Taylor

The agency has given the go-ahead for a Phase I study of the company’s IO-202 antibody (in combination with Merck’s Keytruda) to treat various tumor types.

Parexel, Medidata extend decentralized clinical trial partnership

21-Feb-2022 By Jenni Spinner

The two companies, which have been collaborating for 15 years, reportedly will focus on elevating decentralized trial solutions to develop new therapies.

Emmes contributes data service to pediatric COVID-19 research

21-Feb-2022 By Jenni Spinner

The CRO is helping out on a project exploring the effects of the virus in children; other members of the research team include experts from Duke University.

For rare disease patients, ‘every day is Rare Disease Day’

21-Feb-2022 By Jenni Spinner

On February 23, five days ahead of the day of rare-disease awareness, OSP’s Rare and Orphan Diseases webinar will share insights from top industry experts.

Bayer program streamlines clinical trial process, site relationships

17-Feb-2022 By Jenni Spinner

Created via a joint effort with EY, the pharmaceutical company launched ASPIREs, a program intended to improve its clinical trial processes in numerous areas.

Expect growth, innovation in digital health landscape: BCG Digital Ventures

17-Feb-2022 By Jenni Spinner

In its forward-looking report on digital health, the consulting outfit offers predictions on what changes are ahead and how they might impact the field.

Tech Innovations: February 2022

17-Feb-2022 By Jenni Spinner

This month’s list of announcements about technology, funding, and more includes Medable, Clarify Health, Thermo Fisher Scientific, and other key companies.

Digital therapeutics gaining interest in medical industry: Curebase

15-Feb-2022 By Jenni Spinner

According to a representative from the decentralized trial solutions company, the field of digital therapeutics is poised to gain significant popularity.

Clinical research trends include increased emphasis on study design: Advarra

15-Feb-2022 By Jenni Spinner

An expert from the institutional review board services company advises what trends to look for in the clinical trial industry over the course of coming months.

Collaboration to advance development of cancer therapies

14-Feb-2022 By Jenni Spinner

Cullinan Oncology has formed a strategic partnership with the Icahn School of Medicine at Mount Sinai to research and develop targeted therapies for cancer.

Tech, talent, and partnerships elevate data management: ICON

14-Feb-2022 By Jenni Spinner

In this second of a two-part series, experts from the clinical research organization share thoughts on how data management technology, personnel, and partnerships have evolved.

Merck restructures to strengthen CDMO business

14-Feb-2022 By Jane Byrne

Darmstadt, Germany headquartered, Merck KGaA, is restructuring its life sciences business.

Evolution of clinical trial data calls for evolved response: ICON

10-Feb-2022 By Jenni Spinner

In the first of a two-part series, leaders from the CRO discuss how study data has progressed in recent years and how trial teams can keep up effectively.

TFF completes enrollment in early-phase trial of inhaled COVID-19 therapy

10-Feb-2022 By Nick Taylor

The pharmaceutical company, which uses thin-film freezing to develop inhalable therapies, has completed enrollment in the first phase for its drug candidate.

SCOPE 2022

Breast cancer tops list of most studied disease in 2021: Phesi

09-Feb-2022 By Jenni Spinner

The company’s analysis of trials conducted around the world last year shows cancers took four of the top five positions, with COVID-19 in second place.

SCOPE 2022

Clinical management platform enables vendor visibility: Strategikon Pharma

08-Feb-2022 By Jenni Spinner

Vision, part of the company’s Clinical Maestro platform of software-as-a-solution applications, enables study teams to manage clinical vendor oversight.

Online event to address disparities in cancer research, care

08-Feb-2022 By Jenni Spinner

The latest in the Diversity in Oncology series, taking place February 9, will discuss ways academia and community collaboration can narrow representation gaps.

SCOPE 2022

Persephone looks to decentralized model to boost diversity of cancer study

08-Feb-2022 By Nick Taylor

The precision medicine company is joining with decentralized trial specialist Curebase to bring its cancer studies to a more diverse group of patients.

SCOPE 2022

Real-world evidence ‘central’ to drug development: Parexel

07-Feb-2022 By Jenni Spinner

An expert from the CRO discusses the role real-world data plays in developing therapies, with benefits ranging from speeding recruitment to decreasing costs.

CVS, Medable join forces to expand clinical trial access

07-Feb-2022 By Jenni Spinner

The collaboration between the trial tech company and heathcare firm is aimed at increasing study access at MinuteClinic locations using Medable’s software.

AI can be a powerful tool in drug development, discovery: Tellius

03-Feb-2022 By Jenni Spinner

A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.

People on the Move: February 2022

03-Feb-2022 By Jenni Spinner

This month’s announcements include new hires, promotions, acquisitions, and other events from Saama, Javara, Firma, GlaxoSmithKline, and other companies.

Rare and orphan conditions take center stage during webinar

01-Feb-2022 By Jenni Spinner

During OSP’s exclusive February 23 webinar Rare and Orphan Diseases, leading expertswill lend their unique experience and expertise to the important topic.

WORLD CANCER DAY

Global campaign aims to increase equity in cancer care

01-Feb-2022 By Jenni Spinner

On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.

Altimmune obesity drug candidate lands IND clearance from the FDA

31-Jan-2022 By Jenni Spinner

The pharma firm has announced the agency has approved the company’s investigational new drug application for its Phase II trial of pemvidutide for obesity.

Tufts links decentralized clinical trials to shorter cycle times, cost savings

28-Jan-2022 By Nick Taylor

In a partnership with Medable, a center at the university discovered costs linked to investing in decentralized studies far outweigh the eventual benefits.

SCOPE 2022

Time to change thinking around patient recruitment: Elligo

26-Jan-2022 By Jenni Spinner

A leader from Elligo Health Research (a SCOPE 2022 exhibitor ) discusses flaws in traditional recruitment approaches and offers up some fresh new ideas.

SCOPE 2022

Risk-based quality management ‘perfect’ for DCTs: CluePoints

26-Jan-2022 By Jenni Spinner

A leader from the RBQM solutions specialists offers a preview of his SCOPE 2022 presentation on tools suited to decentralized trial design and management.

SCOPE 2022

Bright ideas, new partnerships, and fun on tap at SCOPE 2022

26-Jan-2022 By Jenni Spinner

The upcoming industry event offers attendees (in-person and virtual) a range of opportunities to learn, connect, and innovate, according to an organizer.

SCOPE 2022

SCOPE award salutes heroic innovation in clinical trial solutions

26-Jan-2022 By Jenni Spinner

One of the finalists for the 2022 Participant Engagement Award (saluting patient recruitment and retention solution) will be announced as winner at SCOPE.

Multi-national studies call for informed approach: Firma Clinical Research

25-Jan-2022 By Jenni Spinner

An expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them.

FDA approves IND for clinical trial evaluating CBD-based drug

25-Jan-2022 By Jenni Spinner

The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientific’s Nantheia ATL5, a candidate for treating opioid use disorder.

Tech Innovations: January 2022

20-Jan-2022 By Jenni Spinner

This month’s list of new technology, partnerships, and other announcements includes items from ObvioHealth, Datavant, HumanFirst, and other industry players.

Will new Facebook ad policy shake up clinical trial recruitment?

20-Jan-2022 By Jenni Spinner

An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment.

UK agency opens future of clinical trials to the public

18-Jan-2022 By Jenni Spinner

The Medicines and Healthcare Products Regulatory Agency has released proposals to bolster trials legislation, asking citizens for input on the suggestions.

Europe launches initiative to transform clinical trials

18-Jan-2022 By Rachel Arthur

Regulatory bodies in the European Union have launched an initiative to develop the region as a focal point for clinical research and to better integrate clinical research in the European health system.

Advanced analytical tech can help keep data clean: Phastar

13-Jan-2022 By Jenni Spinner

Two experts from the CRO discuss artificial intelligence, machine language processing, and other analytical tools that can be useful in data management.

More than ever expected of today’s data managers: IQVIA

13-Jan-2022 By Jenni Spinner

With the amount of available data increasing and technology evolving, says a company leader, the job of data manager is more demanding than ever before.

Managing QC lab data is important part of research equation: Veeva

13-Jan-2022 By Jenni Spinner

A leader from the company discusses challenges in control labs and shares how a new solution aims to clear some key obstacles to greater effectiveness.

Novartis reports good news from COVID-19 antiviral trial

12-Jan-2022 By Jenni Spinner

The pharma firm and collaborator Molecular Partners reported positive data out of their Phase II study for ensovibep, an antiviral for treating the virus.

NervGen Pharma sets sights on trial for spinal-cord injury treatment

12-Jan-2022 By Jenni Spinner

The company plans to launch a Phase Ib/II study of its compound NVG-291 in collaboration with researchers at Northwestern University’s Shirley Ryan AbilityLab.

Sanofi extends its RWD-focused partnership with Evidation

10-Jan-2022 By Jenni Spinner

The collaboration will center on development of unique data sets, which could be used in helping promote better understanding of aspects of human health.

Stand Up To Cancer research initiative targets pancreatic cancer

10-Jan-2022 By Jenni Spinner

Joining with a noted research foundation, the group is aiming for earlier detection and treatment of the disease, which hits nearly 500K people annually.

People on the Move: January 2022

06-Jan-2022 By Jenni Spinner

This month’s news on mergers and acquisitions, hires, and other developments includes notable firms like Altasciences, Protocol First, WuXi STA, and more.

Artificial intelligence could benefit all aspects of clinical trials: IQVIA

04-Jan-2022 By Jenni Spinner

An AI expert discusses progress in the field, gaps in understanding, and how predictive modeling and other advanced analytical tools could be put to use.

Road ahead paved with innovation, opportunities: Syneos Health

04-Jan-2022 By Jenni Spinner

A forward-looking report from company experts includes a breakdown of the top trends to watch for in pharmaceutical development and in healthcare overall.

Lessons learned can help advance the future of DCTs: ObvioHealth

03-Jan-2022 By Jenni Spinner

A leader from the clinical trial technology company says that insights gained during the recent pandemic could be helpful in realizing future improvements.

Dogs, VR, and rock stars: OSP’s favorite items of 2021

22-Dec-2021 By Jenni Spinner

It has been a pleasure for the OSP team to connect with a long list of fascinating industry minds and share the stories; here are a few of our favorites.